论文部分内容阅读
目的:探讨痰热清注射液对支气管肺炎患儿疗效及患儿血清中C反应蛋白(CRP)表达的影响,探讨其临床意义,以积累临床经验,指导临床工作。方法:选取我院诊治的105例支气管肺炎患儿,随机分为观察组(65例)与对照组(40例),对照组应用以头孢噻肟为主的常规治疗,观察组在常规治疗的基础上加用痰热清注射液,观察其疗效,并检测治疗前和治疗后患儿血清中CRP的变化。结果:治疗1周后,观察组治疗的疗效明显优于对照组,观察组与对照组在治疗后血清中C反应蛋白均有下降,但观察组治疗后C反应蛋白的减少值明显大于对照组。结论:痰热清注射液对支气管肺炎患儿疗效明显,并能显著降低患儿血清中的C反应蛋白的浓度,临床中应推广应用。
Objective: To investigate the effect of Tanreqing Injection on the curative effect of children with bronchial pneumonia and the expression of C-reactive protein (CRP) in children with acute bronchial pneumonia, and to explore its clinical significance in order to accumulate clinical experience and guide clinical work. Methods: A total of 105 children with bronchial pneumonia who were diagnosed and treated in our hospital were randomly divided into observation group (65 cases) and control group (40 cases). The control group was treated with cefotaxime as the main routine. The observation group was treated with routine treatment On the basis of adding Tanreqing injection, to observe its efficacy, and detection of pre-treatment and post-treatment serum CRP changes. Results: After 1 week of treatment, the curative effect of the observation group was obviously better than that of the control group. The serum C-reactive protein in the observation group and the control group decreased after treatment, but the reduction of C-reactive protein in the observation group was significantly greater than that of the control group . Conclusion: Tanreqing Injection has obvious curative effect on children with bronchopneumonia and can significantly reduce the concentration of C-reactive protein in children’s serum, which should be widely applied in clinic.